A Pilot Study to Evaluate Multi-Spectral Imaging and Laser Speckle Imaging During Vascular Occlusion
|Study Design:||Observational Model: Case-Only
Time Perspective: Cross-Sectional
|Official Title:||A Pilot Study to Evaluate Multi-Spectral Imaging and Laser Speckle Imaging During Vascular Occlusion|
- Skin blood flow [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
|Study Start Date:||November 2011|
|Estimated Study Completion Date:||November 2018|
|Estimated Primary Completion Date:||November 2018 (Final data collection date for primary outcome measure)|
Multi-Spectral & Laser Speckle Imaging
Device: Multi-Spectral & Laser Speckle Imaging
Changes in skin tissue and blood flow.
The primary reason for including pressure cuff occlusion in this protocol is to test the performance of Multi-Spectral Imaging and Laser Speckle Imaging can measure in the full range of vascular conditions ranging from ischemic (under-perfused or unsaturated) to hyperemic (over-perfused and over-saturated).
- .Modulated Imaging a non-contact optical imaging technology can detect the concentration of total hemoglobin, deoxygenated and oxygenated hemoglobin in absolute amounts in units of millimoles / unit volume of tissue measured.
- . Laser Speckle Imaging a non-contact optical imaging technology consists of a coherent light source, camera, and image acquisition system. This image device can measure and compare relative flow in vasculature at varied time points.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01484730
|Contact: Ata Sharif, MDfirstname.lastname@example.org|
|United States, California|
|Beckman Laser Institute, UCI||Recruiting|
|Irvine, California, United States, 92612|
|Contact: Ata Sharif, MD 949-824-9265 email@example.com|
|Sub-Investigator: Kristen M Kelly, MD|
|Sub-Investigator: Bernard Choi, Ph.D.,|
|Principal Investigator:||Anthony Durkin, PhD||Beckman Laser Institute, UCI|